New health concerns about 'fake pot' in US
A type of fake pot has raised new health concerns in the United States after at least three users were hospitalized for kidney failure, authorities in the western state of Wyoming said Monday.
Often known as "Spice" or "K2," the substance is marketed to young people as herbal incense, and creates a marijuana-like high when it is smoked like a joint or a cigarette.
"At this point we are viewing use of this drug as a potentially life-threatening situation," Tracy Murphy, state epidemiologist with the Wyoming Department of Health, said in a statement sent to AFP.
State health authorities first learned of the latest incidents on Thursday involving three patients in central Wyoming who sought hospital care after smoking a product known as "blueberry spice," a spokeswoman added.
There have been no deaths and no reports of connected cases in other areas, she added.
However, drug policy experts say that fake pot use has been on the rise in recent years, ever since it was first copied from a US scientist's lab research in the mid 1990s and quickly spread around the world.
The compound, known as JWH-018, was created in the lab of John Huffman, a professor of organic chemistry at Clemson University, who was researching how marijuana-like compounds act on brain receptors.
According to the US Drug Enforcement Agency, which in 2011 banned JWH-018 and four other synthetic cannabinoids, calls to poison control centers rose from just over 100 in 2009 to more than 2,700 nationwide in the space of a year.
"Technically it is an incense, it is not for human consumption, you know what I am saying?" said a smoke shop owner in Arizona who asked not to be named.
He said he continues to stock three kinds of herbal incense, but none that carry ingredients outlawed by the DEA.
"If there is a banned substance in there, then we don't have it in our store," he told AFP by phone, adding that brands and popularity change frequently.
"You know, people go from their K2 to their Dead Man Walking, to their Smoking Camel, there is all kinds of stuff out there," he said.
"I'll be happy when it's gone."
(c) 2012 AFP
-
US bans 'fake' marijuana chemicals
Nov 24, 2010 |
not rated yet |
0
-
SLU toxicologist warning to parents: Look for signs of K2
Mar 03, 2010 |
not rated yet |
0
-
Survey: Teen pot use rises, alcohol use declines
Dec 14, 2011 |
not rated yet |
0
-
Synthetic drugs send thousands to ER
Apr 07, 2011 |
not rated yet |
0
-
New tests for 'legal marijuana,' 'bath salts' and other emerging designer drugs
Aug 31, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
Medications
7 hours ago |
not rated yet |
0
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications
May 23, 2013 |
1 / 5 (1) |
0
J&J expects 10-plus new drug applications by 2017
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications
May 23, 2013 |
5 / 5 (1) |
0
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
May 22, 2013 |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Driving and hands-free talking lead to spike in errors, study shows
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.